NASDAQ:ATRC AtriCure Q3 2026 Earnings Date & Estimates $57.30 +0.43 (+0.76%) Closing price 10/14/2026 04:00 PM EasternExtended Trading$57.31 +0.01 (+0.01%) As of 04:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. AtriCure is scheduled to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 3, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from AtriCure in Q3 2026AtriCure is expected to post earnings of -$0.0427 per share on revenue of $151.15 million. In the same quarter a year earlier AtriCure reported -$0.01 per share on revenue of $134.27 million. AtriCure last reported on July 23, 2026, posting $0.18 per share and beating the -$0.0017 consensus estimate. AtriCure has beaten the consensus EPS estimate in 6 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.0427Expected Revenue$151.15 millionPrior-Year EPS-$0.01Prior-Year Revenue$134.27 millionExpected Revenue Growth+12.6%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.18 (Beat by +$0.1817)Last Quarter Revenue$153.60 millionEPS Beat Rate6 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ4 2025 Earnings ReportQ3 2025 Earnings Report AtriCure Q3 2026 Earnings FAQ When does AtriCure report Q3 2026 earnings? AtriCure (NASDAQ:ATRC) has confirmed it will report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. What time is AtriCure's Q3 2026 earnings call? AtriCure's Q3 2026 earnings conference call is scheduled for Tuesday, November 3, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for AtriCure? Analysts expect AtriCure to post earnings of -$0.0427 per share for Q3 2026. How much revenue is AtriCure expected to report? The consensus revenue estimate for AtriCure is $151.15 million for Q3 2026. AtriCure Earnings HeadlinesAtriCure (NASDAQ:ATRC) Stock Price Target Raised at BTIG ResearchOctober 12 at 8:12 AM | americanbankingnews.comAtriCure (ATRC) Stock Gets Fair Value Bump As Analysts Weigh Procedure Growth And RisksOctober 4, 2026 | finance.yahoo.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely. | Altimetry (Ad)Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Atricure (ATRC)October 4, 2026 | theglobeandmail.comConfira a cotação ATRC hoje e acompanhe as ações AtriCure em tempo real.September 27, 2026 | br.investing.comAtriCure (ATRC) Stock Looks Rich Against Its Sales BaseSeptember 25, 2026 | finance.yahoo.comSee More AtriCure Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like AtriCure? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AtriCure and other key companies, straight to your email. Email Address About AtriCureAtriCure (NASDAQ:ATRC) is a medical device company focused on developing and commercializing technologies for the treatment of atrial fibrillation (AF) and related cardiac conditions. Its products are used primarily in cardiac surgery and electrophysiology procedures to create surgical lesions that interrupt abnormal electrical signals in the heart. The company’s portfolio includes the AtriCure Isolator Synergy ablation system, cryoablation products sold under the cryoICE brand, and the AtriClip system for the exclusion of the left atrial appendage, a potential source of blood clots in patients with AF. AtriCure also offers the EPi-Sense system, which is used in hybrid and minimally invasive procedures for AF treatment, as well as technologies designed to support the management of post-operative pain. Founded in 2000, AtriCure is headquartered in Mason, Ohio. The company serves hospitals, cardiac surgeons, electrophysiologists and other healthcare providers in the United States and international markets through direct operations and distribution relationships. Its products are intended to support open, minimally invasive and hybrid approaches to cardiac care.View AtriCure ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Citi Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver?PBF Energy's Stunning Rally Faces a Critical TestA Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Albertsons Is Betting on a Turnaround—But Will It Pay Off?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American Business Upcoming Earnings Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
